Cytosurge AG

Cytosurge AG Driving the revolution. We provide scientists with FluidFM® to read and analyze life as it unfolds.

CellEDIT delivers vector-free, precise CRISPR engineering, even in hard-to-transfect cells.
👉 https://linktr.ee/cytosurge Cytosurge develops innovative research solutions using its proprietary FluidFM® technology for precise single-cell manipulation thereby fostering advancements in understanding cellular processes such as the ones that drive cancer. With the FluidFM OMNIUM platform, single-cell

extracts, or “biopsies” can be taken from living cells, enabling live-sequencing and temporal transcriptomics analysis. Additionally, the CellEDIT Service provides high-quality genetically engineered cell lines through intra-nuclear injections of CRISPR RNPs. Cytosurge's vision is to unlock novel cures by translating next-generation genetic designs into living cells, enabling longer and healthier lives through precision gene engineering. The Company aims to implement advanced genetically engineered cell lines that bring next-generation therapies to fruition, bridging the gap between genetic design tools and manufacturing, and empowering genetic engineers to realize their visionary concepts.

A brilliant new application of   in  ! 🧫🔬In a new eLife paper, researchers at ETH Zurich combined FluidFM with FLIM to m...
18/06/2026

A brilliant new application of in ! 🧫🔬
In a new eLife paper, researchers at ETH Zurich combined FluidFM with FLIM to map how living cells transmit physical forces to their organelles.
How? FluidFM enabled them to simultaneously:🔹 Mechanically indent specific subcellular compartments (like the nucleus)🔹 Inject cytoskeletal disruptors directly into the exact same cell
This dual mechano-chemical approach revealed real-time tension dynamics across actin, microtubules, and lamins. Huge congratulations to the authors on pushing the boundaries of single-cell precision!

Link to the full paper in the first comment 👇

Missed us at  ? Do not fear, our   service is available worldwide. 🌍🔬 If you're dealing with hard-to-transfect lines or ...
16/06/2026

Missed us at ? Do not fear, our service is available worldwide. 🌍🔬 If you're dealing with hard-to-transfect lines or complex iPSC edits, standard transfection methods often leave you with random dosing, high toxicity, and off-target edits. Powered by our technology, CellEDIT uses direct intra-nuclear injection to deliver RNPs without the chemical stress, giving you clean, verified clones with high viability.

Swipe through to see why researchers around the globe are trusting CellEDIT for their most complex genome engineering projects.
👇 Download the complete 2-pager from the link in the first comment!

The versatility of   is changing how we study cancer at the single-cell level. 🔬 Want to see how? Catch Dr. Ludovica Riz...
10/06/2026

The versatility of is changing how we study cancer at the single-cell level. 🔬 Want to see how? Catch Dr. Ludovica Rizzo’s poster presentation today at !

She’ll be sharing new data on how the FluidFM OMNIUM platform enables non-destructive . Learn how to sequence your cancer cells while keeping them alive, allowing you to track dynamic biological responses in the exact over time.

📍 Poster P-221 ⏰ 18:40-20:00 (the poster is already up if you want to already have a look at it).

Come see the data, or visit us at Booth #120 to talk biology and get some goodies.

17 years ago today, Cytosurge was founded with a single, ambitious goal: to bring unprecedented precision to the single-...
09/06/2026

17 years ago today, Cytosurge was founded with a single, ambitious goal: to bring unprecedented precision to the single-cell level and lay the foundation for Biology.. 🎂🔬
Since June 9, 2009, we’ve been pushing the boundaries of what’s possible in single-cell manipulation and genome engineering. From the early days of developing technology to launching our OMNIUM platform for biology and the CellEDIT Service for complex CRISPR models, our mission has remained the same: empowering researchers to bypass bottlenecks and capture true biological complexity without destroying their samples.
Thank you to our incredible team, our partners, and the brilliant scientific community who trust our technology to drive their discoveries forward.

Here’s to the next chapter of innovation! 🚀

Day 2 at  ! 🔬 We love the "aha!" moment when researchers realize they can finally bypass standard single-cell bottleneck...
09/06/2026

Day 2 at ! 🔬 We love the "aha!" moment when researchers realize they can finally bypass standard single-cell bottlenecks.

Come to Booth #120 and tell us your toughest research challenge. With our technology, you can: ✨ Sequence cells while keeping them alive ( ) ✨ Build "impossible" CRISPR models ( ) ✨ Push the boundaries of biology >your imagination is the limit!

Drop by, take our quiz, and win some Swiss chocolate! 🍫

We're ready to welcome you at Booth  #120 for  ! 👋 Drop by to discover how to move beyond single-cell snapshots and sequ...
08/06/2026

We're ready to welcome you at Booth #120 for ! 👋 Drop by to discover how to move beyond single-cell snapshots and sequence your cells while keeping them alive.
Plus, try to win some authentic Swiss chocolate with our quiz! 🍫

LIVE from day one at   in Budapest! 🔬Booth  #120How do you track the transcriptional drivers of cancer metastasis as the...
08/06/2026

LIVE from day one at in Budapest! 🔬Booth #120
How do you track the transcriptional drivers of cancer metastasis as they happen? Standard sequencing gives you a terminal snapshot. But to truly understand dynamic processes like epithelial-to-mesenchymal transition (EMT), you need to track the exact over time.
Check out our EMT use-case flyer below 👇 (Download the full flyer via the link in the first comment!)

See how to use the OMNIUM platform to take non-destructive biopsies from a at multiple time points. Correlate transcriptomic data with cellular morphology and capture the gene expression patterns driving intermediate states, without destroying your sample.
At the conference? Visit us at Booth #120 to talk !

🔬 We’re looking forward to joining the cancer research community at EACR 2026 in Budapest!Stop by booth  #120 to see how...
28/05/2026

🔬 We’re looking forward to joining the cancer research community at EACR 2026 in Budapest!
Stop by booth #120 to see how our OMNIUM platform is advancing biology in oncology. We’re supporting researchers with non-destructive Live-seq, enabling you to sample and study the exact same living cancer cells over time to track drug responses, resistance mechanisms, and tumor heterogeneity without destroying your samples.

👋 Come chat with the team and stop by our poster on June 10th, where Dr. Ludovica Rizzo will share how we’re moving beyond one-time cellular snapshots to capture true dynamic biological responses in cancer models.
On-site, also Eric Butillon, Andrea Leiser, and Erica Fiorini. A big team for a big event!

We are thrilled to announce our new partnership with Swift Analytical Ltd as the exclusive distributor of the FluidFM OM...
26/05/2026

We are thrilled to announce our new partnership with Swift Analytical Ltd as the exclusive distributor of the FluidFM OMNIUM platform in the UK! 🚀 As a trusted, family-owned distributor with deep expertise in cell analysis and sorting, Swift Analytical is the perfect partner to bring our technology to the UK scientific community. 🧬

UK researchers 📢 Don't let destructive methods bottleneck your discoveries. offers a truly non-destructive solution for longitudinal profiling (Live-seq, proteomics, metabolomics), mechanobiology, and single-cell manipulation. Preserve your cells & get more data 📨Message Swift Analytical to bring it to your lab!

Beyond their technical expertise, Swift Analytical stands out for its dedication to ethical solutions and giving back to the community. 🌍 We are proud to partner with a team that values both scientific and social impact.

How do you study complex receptor signaling without background noise interfering with your readouts? You start with a pe...
21/05/2026

How do you study complex receptor signaling without background noise interfering with your readouts? You start with a perfectly clean cellular background. 🧫✨
We recently sat down with Dr. Shixin Ye-Lehmann ( ) to discuss her team's work on the Hedgehog signaling pathway and the SMO receptor using synthetic biology. 🔬
To get clean readouts for their functional assays, they needed a precise SMO gene knockout in SK-OV-3 cells. They didn't just need a simple mutation; they needed a complete, homozygous deletion to ensure zero background interference. 🧬

Using a double-guide approach and single-cell isolation, successfully deleted the region between exons 2 and 6, delivering the verified homozygous knockout clones needed to move their research forward. 🚀
Read the full conversation and see how CellEDIT enables breakthrough synthetic biology research. Link in the first comment 👇

Adresse

Sägereistrasse 25
Glattbrugg
8152

Öffnungszeiten

Montag 09:00 - 18:00
Dienstag 09:00 - 18:00
Mittwoch 09:00 - 18:00
Donnerstag 09:00 - 18:00
Freitag 09:00 - 18:00

Telefon

+41445331450

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Cytosurge AG erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Teilen